Physician profile
Michael Grimes
NPI 1275500720
$4,884.00
in general payments reported to CMS, 2019-2025
21 companies · $704 in 2025
The $704 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,510 · 2020: $210 · 2021: $609 · 2022: $769 · 2023: $680 · 2024: $401 · 2025: $704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,785.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,681.51 | 2019-2025 | Collagenase Santyl, Stravix Pl, Stravix |
| Bioventus LLC | $633.59 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $569.81 | 2019-2025 | Puraply, Puraply Wound Matrix |
| Treace Medical Concepts, INC. | $364.17 | 2022-2024 | |
| Zimmer Biomet Holdings, INC. | $341.43 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $276.55 | 2020-2023 | |
| Depuy Synthes Sales INC. | $156.50 | 2025 | Motoband |
| Wright Medical Technology, INC. | $150.30 | 2019-2020 | |
| Horizon Therapeutics Plc | $124.98 | 2019 | |
| Crossroads Extremity Systems, LLC | $108.11 | 2019 | |
| Paratek Pharmaceuticals, INC. | $99.19 | 2025 | Nuzyra |
| Osiris Therapeutics INC. | $92.12 | 2019 | |
| Rikco International, LLC | $85.47 | 2019 | |
| Orthofix Medical, INC. | $72.48 | 2022-2025 | Physio-Stim, Accelstim |
| Vertex Pharmaceuticals Incorporated | $23.89 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $23.79 | 2025 | Augment Injectable |
| Apria Healthcare LLC | $17.20 | 2021 | |
| Paragon 28, INC. | $16.71 | 2019 | |
| Arthrosurface Incorporated | $16.53 | 2019 | |
| Abbott Laboratories | $16.28 | 2021 | |
| Reprise Biomedical, INC. | $13.39 | 2024 | Miro3d |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Grimes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.